Provision of Balanced Nutrition Protects Against Hypoglycemia in the Critically Ill Surgical Patient

2012 ◽  
Vol 2012 ◽  
pp. 208-209
Author(s):  
J.M. Daly
Surgery ◽  
1996 ◽  
Vol 120 (4) ◽  
pp. 752-759 ◽  
Author(s):  
Peter K. Henke ◽  
Hiram C. Polk

2011 ◽  
Vol 106 (4) ◽  
pp. 610
Author(s):  
R.J.T. Wilson

2011 ◽  
Vol 9 (3) ◽  
pp. 133-134
Author(s):  
Inge Hommel ◽  
Petra J. van Gurp ◽  
Cees J. Tack ◽  
Hub W. Wollersheim ◽  
Marlies E.J.L. Hulscher

2018 ◽  
Author(s):  
Brett A Melnikoff ◽  
René P Myers

Fungal infections remain an important cause of morbidity and mortality in surgical settings, with critically ill patients, transplant recipients, and sick neonates all especially vulnerable. Over the past few decades, technological and scientific advancements have improved physicians’ ability to sustain life in critically ill patients; developments in chemotherapeutics and immune-based therapies have yielded increased survival for many cancer patients; organ transplantation has evolved dramatically; and the use of invasive therapies (eg, ventricular assist devices) has increased markedly. With these changes has come an increase in the incidence of serious fungal infections, including the less common but potentially fatal noncandidal infections caused by Aspergillus and the Zygomycetes Mucor and Rhizopus. This review outlines an approach to the workup and management of the nonneutropenic surgical patient with a suspected noncandidal infection (aspergillosis and zygomycosis). Figures show biopsy samples from an elderly man with chronic progressive disseminated histoplasmosis and thick-walled, broad-based budding yeasts typical for Blastomyces dermatitidis on biopsy material. This review contains 2 figures and 47 references Key words: aspergillosis, aspergillosis prophylaxis, blastomycosis, Cryptococcus, histoplasmosis, noncandidal fungal infections  


2018 ◽  
Author(s):  
Sharon Wilson ◽  
Kaitlin A. Pruskowski

Management of critically ill surgery patients is challenging, coupled not only with the acute ICU needs, but surgical changes as well. These patients often require multiple medications, and proper dosing and monitoring is necessary to achieve optimal outcomes and avoid adverse drug events. Understanding the pharmacokinetic changes in this population is important for managing drug therapies and improving patient care outcomes. The purpose of this chapter is to introduce the clinician to changes in pharmacokinetics in the critically ill surgery patient and provide practical applications for drug management when faced with these challenges. This review covers the basics of drug management, pharmacokinetic alterations, drug classes and pharmacokinetic changes in the critically ill surgery patient, select disease states, and pharmacokinetic alterations in select conditions. This review contains 4 figures, 10 tables and 105 references Key Words: Pharmacokinetics, surgery, critical care, therapeutic drug monitoring  


BMJ ◽  
2007 ◽  
Vol 335 (7628) ◽  
pp. s185-s185
Author(s):  
Rajesh Nair

1996 ◽  
Vol 89 (Supplement) ◽  
pp. S13
Author(s):  
Susan C. Harvey ◽  
Michael OʼNeill ◽  
Teresa Alison ◽  
Karl Byrne ◽  
Douglas Norcross

Sign in / Sign up

Export Citation Format

Share Document